First Report of Sylvatic DENV-2-Associated Dengue Hemorrhagic Fever in West Africa by Franco, Leticia et al.
First Report of Sylvatic DENV-2-Associated Dengue
Hemorrhagic Fever in West Africa
Leticia Franco
1*
., Gustavo Palacios
2., Jose ´ Antonio Martinez
3, Ana Va ´zquez
1, Nazir Savji
2, Fernando De
Ory
1, Marı ´a Paz Sanchez-Seco
1, Dolores Martı ´n
4, W. Ian Lipkin
2, Antonio Tenorio
1
1National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain, 2Center for Infection and Immunity, Mailman School of Public Health,
Columbia University, New York, New York, United States of America, 3Hospital Infanta Cristina, Parla, Madrid, Spain, 4Laboratorio Br Salud, San Sebastia ´n de los Reyes,
Madrid, Spain
Abstract
Dengue virus (DENV) circulates in human and sylvatic cycles. Sylvatic strains are both ecologically and evolutionarily distinct
from endemic viruses. Although sylvatic dengue cycles occur in West African countries and Malaysia, only a few cases of
mild human disease caused by sylvatic strains and one single case of dengue hemorrhagic fever in Malaysia have been
reported. Here we report a case of dengue hemorrhagic fever (DHF) with thrombocytopenia (13000/ml), a raised hematocrit
(32% above baseline) and mucosal bleeding in a 27-year-old male returning to Spain in November 2009 after visiting his
home country Guinea Bissau. Sylvatic DENV-2 West African lineage was isolated from blood and sera. This is the first case of
DHF associated with sylvatic DENV-2 in Africa and the second case worldwide of DHF caused by a sylvatic strain.
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Introduction
Dengue viruses (DENV) are the most widely distributed
arboviruses in the world. The four distinct serotypes belong to
the family Flaviviridae and are some of the most important vector-
borne pathogens of humans [1]. DENV circulation occurs in two
cycles: an endemic/epidemic cycle between humans and perido-
mestic mosquitoes, Aedes aegypti and Ae. albopictus, and a sylvatic
enzootic cycle between non-human primates and several arboreal
Aedes species. In Asia, circulation of sylvatic DENV-1, -2 and -4
has been detected in Ae. niveus mosquitoes and/or sentinel monkeys
[2]. Although sylvatic DENV-3 strains have not been isolated to
date, they are believed to circulate in Malaysia based on
seroconversion of sentinel monkeys [3,4]. In Africa, only sylvatic
DENV-2 has been reported as associated with Ae. luteocephalus, Ae.
taylori, Ae. furcifer and other forest gallery mosquitoes [5]. Sylvatic
DENV strains are ecologically and evolutionary different from
endemic strains [6] and the Asian (Malaysia) and West African
lineages of sylvatic DENV-2 are clearly divergent [7].
Since the 1970s in Africa, sylvatic DENV-2 has been detected
primarily in mosquitoes in south eastern Senegal (Kedougou
region), but also in Guinea, Ivory Coast and Burkina Faso
[5,7,8,9] with sporadic isolations from humans and monkeys
[10,11,12,13]. Epizootic DENV-2 was first described in the region
of Kedougou in Senegal in 1974, and successively in 1980-82,
1989-90 and 1999-2000, with a periodicity of approximately 8 to 9
years [5]. The first isolation of sylvatic DENV-2 from a human
was reported in 1970 in Bandia, Senegal (sixty kilometers east of
Dakar) from a young girl [14,15]. Subsequently, DENV-2 was
isolated in 1983 from a French expatriate in south western Senegal
in the Casamance region [13] bordering the Gambia and Guinea
Bissau (Figure 1) and in 1990 in south eastern Senegal [10].
The first documented outbreak of sylvatic DENV in humans
was identified in a retrospective study on samples collected in
Ibadan, Nigeria from August 1964 to December 1968 [16].
Thirty-two strains of DENV were recovered of which 14 were
DENV-2 [12]. Three complete genomes from samples taken in
1966 were obtained and analyzed and found to be West African
sylvatic DENV-2 [16]. These findings suggested that DENV-2 was
enzootic in West Africa at least 40 years ago with a limited
spillover into humans. More recently, in Malaysia in 2005, a
DENV-1 detected from a febrile patient clustered with the
ancestral sylvatic DENV-1 isolated from a sentinel monkey in
1972 (strain P72_1244)[17]. However, recent evidence based on
complete genome phylogenetic analysis suggests this strain falls
into the human dengue diversity of endemic DENV-1 [18].
The epidemic and pathogenic potential of sylvatic DENV
strains remains controversial. Some authors argue that sylvatic
viruses do not pose a threat to public health [19]. In 2008, two
events were linked to sylvatic dengue virus activity in humans in
West Africa and Asia. Two imported dengue fever cases were
reported in France in travelers returning from West Africa, Mali
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in a town 450 km from Bamako, Mali [21]. Genetic analysis of
isolates from both sites revealed 99.6% sequence identity;
phylogenetic analysis revealed that all sequences clustered with
the West African sylvatic DENV-2 [21]. Almost simultaneously,
the first documented case of dengue hemorrhagic fever (DHF)
involving sylvatic DENV was observed in Malaysia [22]. A student
returning from a trip to peninsular Malaysia was diagnosed with
grade II DHF associated with sylvatic DENV-2. This 2008
Malaysian strain sequence [22] clustered with the sequences of
Asian sylvatic dengue strains recovered from monkeys in the
1970s.
Here, we report the first African case of DHF associated with
sylvatic DENV-2 of a West African lineage.
Materials and Methods
Case introduction description
A previously healthy young male native to Guinea Bissau, but
living in Spain, was admitted to Emergency Services at the Infanta
Cristina Hospital, Madrid, Spain. The patient had returned to
Madrid after a 3-month trip to his home country. When admitted,
the patient presented with fever, headache, conjunctival hyper-
emia, and musculoskeletal pain. He did not have nausea, vomiting,
voiding symptoms, or skin lesions. Cardiopulmonary examination
yielded no findings. The patient was normotensive with good
baseline oxygen saturation. He had not received any type of
prophylaxis for malaria or other agents before the trip. During
hospitalization, blood samples were obtained for virological and
serological testing at the National Centre of Microbiology (CNM),
Instituto de Salud Carlos III. Dengue case classification and
management was performed according to WHO criteria [23] and
subsequently adjusted to the new WHO/TDR guidelines [24].
Ethics statement
The institutional review board at the Instituto Carlos III
approved this study under the PI08/0834 identification. Through
this protocol, the patient’s identity was un-linked from the sample,
test result, and Genbank accession number. EEB-17 is an arbitrary
identifier assigned to the viral culture sample used to sequence the
genome and thus cannot be linked with the patient’s identity.
Virological and serological testing
Whole blood and serum obtained at 5 and 6 days post onset
respectively were processed for virological and serological tests
(Table 1). Viral isolation was attempted from serum and blood
samples inoculated into C6/36 mosquito cells. Five days post
infection; cells were harvested after observation of evident
cytopathic effect. This viral isolate was assigned the strain name
Figure 1. Geographical context. Map of Senegal showing regions and boundaries’ with: The Gambia, Guinea Bissau and Mali. Areas with report of
sylvatic dengue activity are signaling by red stars. Canchungo town is underlined. The patient travelled from Canchungo to Dakar through
Casamance, Central Senegal and Capt Vert-Thies regions. Figure was created using maps from http://www.worldofmaps.net (The map of Senegal is
licensed under the Creative Commons Attribution-Share Alike 3.0 and the map of Africa is created by the NASA and is of public domain).
doi:10.1371/journal.pntd.0001251.g001
Author Summary
Dengue viruses are mosquito borne pathogens that cause
up to 100 million infections annually. Dengue viruses
circulate in either humans or non-human primates in two
separate cycles: human and sylvatic. All four different
serotypes infect humans causing frequent epidemics and
severe disease, including hemorrhagic fever. Until a few
years ago, viruses circulating in the sylvatic cycle had been
associated with asymptomatic to mild disease only in
humans. For example, retrospective analysis of human
serum samples collected in Nigeria from the 1960s proved
that sylvatic dengue was able to cause an outbreak of
dengue fever in human population. Recently a case of DHF
in Asia was linked to sylvatic DENV-2 (strain DKD811)
infection. Here, we report the first case of DHF associated
with sylvatic DENV-2 infection in Africa caused by a
complete different lineage of the virus. All these events
underscore the need to be vigilant about the re-
emergence of DHF from sylvatic cycles.
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assay using the commercial monoclonal antibody 8702 (clone
3H5-1), (Chemicon, Temecula, CA, USA). Viral supernatant was
inactivated in lysis buffer (AVL, Qiagen, Valencia, CA, USA) for
nucleic acid extraction and PCR amplification.
IgM and IgG antibodies were determined by capture and
indirect-ELISA, respectively (Panbio, QLD, Australia). As previ-
ously described [25], IgM reactivity was confirmed by the
performance of a background assay (e.g. parallel assessment with
presence or absence of antigen). NS1 antigenemia was determined
by using PLATELIA dengue NS1 capture Antigen ELISA
(BioRad, Marnes la Coquette, France). Finally, to differentiate
primary from secondary infection an avidity IgG test was done
[25].
Sera, blood and viral supernatants, inactivated with AVL/
carrier RNA solution Buffer (Qiagen), were RNA extracted with
the QIACube (Qiagen) extractor. RT-PCR and product sequenc-
ing were performed as previously described [26]. A different RT-
PCR technique that amplifies 1019 bp of the NS5 flaviviral gene
[27] was used as a confirmatory test in the supernatants of the viral
isolates. RT-PCR products were detected by gel electrophoresis
and purified by the QIAquick PCR purification kit (Qiagen) and
sequenced with ABI prism Big Dye terminator cycle sequencer
v3.1 ready reaction (Applied Biosystem, Foster City, CA, USA)
and analyzed on the ABI prism 377 DNA Analyzer (Applied
Biosystem).
To sequence the genome, primers were designed to produce
amplicons of 1000 bps with 500 bp overlaps based on Dengue
virus type 2 isolate Dak Ar D75505, complete genome
(EF457904), which was, based on similarity analysis of the
consensus NS5 PCR amplicon, the closest relative to our strain
(Table S1). A total of 31 amplicons, approximately 900 bps in
length were used to produce 62 chromatograms. This provided
greater than four times coverage of the complete genome with
400–450 bp overlap amongst one another. The accession number
of the complete genome of EEB-17 is JF260983, which is
10,176 bps long and includes the complete open reading frame
of the polyprotein.
Conventional PCRs were performed with HotStar polymerase
(Qiagen) on PTC-200 thermocyclers (Bio-Rad, Hercules, CA,
USA): an enzyme activation step of 5 min at 95 uC was followed
by 45 cycles of denaturation at 95uC for 1 min, annealing at 55uC
for 1 min, and extension at 72uC for 1 min. Amplification
products were size fractionated by electrophoresis in 1% agarose
gels, purified (MinElute, Qiagen), and directly sequenced in both
directions with ABI PRISM Big Dye Terminator 1.1 Cycle
Table 1. Analytical and virological findings.
Days post onset (date)
4
a(11/09) 5
b(11/10) 6
c(11/11) 7(11/12) 8(11/13) 9(11/14) 10(11/15) 11(11/16) 12
d(11/17) 24
e(11/29)
Platelet (mL) 25000 19000 13000 14000 16000 32000 51000 81000 103000 211000
White cells (mL) 3700 3900 11600 14500 7200 5000 6000 5680 5600 3460
Hemoglobin (g/dL) 16.9 17.3 16.1 14.5 14 13.5 14 14.5 15.1 13.6
Hematocrit (%) 51.2 51.8 48.2 43.5 42 40.4 41.9 42.4 45.3 39.1
Hemoconcentration (%) 30.9
f 32.5
f 23.3
f 11.3 7.4 3.3 7.1 8.4 16 -
Ac protrombin (%) 78 81.6 104 98.6 104 102 95
Crp (mg/dL) 0.9 0.7 0.6 0.7 0.6 0.7 0.8 0.7
GLU (mg/dl) 85 99 75 67 67 78 77 85
GPT (U/L) 52 80 133 207 162 156 160 64
GOT (U/L) 134 188 377 620 429 208 185 50
GGT (U/L) 230
LDH (U/L) 1249 1270 747 523 503 246
Tot Bilirub. (mg/dL) 0.5 0.4 0.4 0.2 0.2 0.3 0.5 0.2
Alk. Phosp. (U//L) 105 99 124 110 96 106
C Reactive Protein (U/L) 9.8 7.4 9.2 10.3 ,5 0.1 0.1
MAC-ELISA(OD) 40.9
ELISA IgG (OD) 58.8
IgG Avidity ELISA High avidity
NS1 Antigen (OD) 10.8
RT-PCR (E/NS1) Positive Positive
Virus isolation DENV-2 DENV-2
RT-PCR(NS5)
g Positive Positive
OD: adjusted optical densities.
aDay of admission.
bDay whole blood was obtained.
cDay serum was obtained.
dDay of discharge.
eDay of re-evaluation.
f.20% of hemoconcentration.
gin viral isolates.
doi:10.1371/journal.pntd.0001251.t001
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Biosystems).
Phylogenetic analysis
To determine the evolutionary history of isolate EEB-17, we
performed a phylogenetic analysis on all available complete genome
sequences of DENV-2 (total alignment length of 10,173 nt; 906
sequences, Oct 15, 2010). First, we performed a clustering analysis
to group available sequences at 97; 95 and 90% similarity using the
CD-HIT clustering program at http://weizhong-lab.ucsd.edu/
cdhit_suite/cgi-bin/index.cgi. This step allowed us to exclude
similar sequences, identify clusters corresponding with known
lineages and identify the more divergent members of each cluster
for proper phylogenetic analysis.
After identification of clusters in correspondence with the
accepted groupings of DENV-2 genotypes, we identified repre-
sentative sequences from each separate cluster to perform deep
phylogenetic analysis. Specifically, we inferred a Maximum Clade
Credibility (MCC) tree using the Bayesian Markov Chain Monte
Carlo (MCMC) method available in the Beast package [28],
thereby incorporating information on virus sampling time. This
analysis utilized a strict molecular clock and a GTR+C model of
nucleotide substitution for each codon position, although very
similar results were obtained using other methods (data available
upon request). The analysis used a Bayesian skyline model as a
coalescent prior as was recently reported in a similar study [22].
All chains were run until convergence for all parameters with 10%
removed as burn-in.
The analysis also allowed us to estimate divergence times for
each node in the DENV-2 genotypes. The degree of uncertainty in
each parameter estimate is provided by the 95% highest posterior
density (HPD) values, while posterior probability values provide an
assessment of the degree of support for each node on the tree.
Results
Clinical and epidemiological data
On November 9, 2009, a 27-year-old man travelling from
Guinea Bissau was admitted to the Hospital Infanta Cristina in
Parla, Madrid, after returning from his home country. He had
spent 3 months in the city of Canchungo, in the northwestern
coast of Guinea Bissau. The patient had initiated his return trip
from Canchungo to Dakar, Senegal on October 28, by car,
through the Casamance region in south-western Senegal
(Figure 1). He stayed in Dakar for approximately a week before
travelling by air to Spain.
On November 6, the patient arrived in Madrid. He reported
feeling ill during the flight. At admission, he presented with fever
(38.6 uC), conjunctival hyperemia, headache and musculoskeletal
pain but no nausea or vomiting, voiding symptoms, or skin lesions.
During his intake history, the patient reported insect bites during
his recent travel to Dakar.
Laboratory investigation demonstrated leukopenia with marked
left shift, and significant thrombocytopenia (13000/ml). No
alteration of clotting time was observed. Renal function was
normal. Liver function impairment was demonstrated by elevated
lactate dehydrogenase (LDH), alanine transminase (ALT) and
aspartate transaminase (AST). Normal values were obtained for
total bilirubin (TBIL) and direct bilirubin, gamma glutamyl
transpeptidase (GGT), amylase and lipase demonstrating normal
cholestasis data (Table 1). Radiological studies of the chest and
abdomen were normal.
After admission to internal medicine service for fever and
thrombocytopenia, the patient experienced epigastric pain,
without hemodynamic compromise. Follow-up analytical testing
showed a progressive decline in platelet numbers, elevated liver
enzymes and hemoglobin with normal bilirubin. Malaria, parasites
in blood, feces and urine, as well as HIV, HAV, HCV and HBV
infections were ruled out. Considering the epidemiological context
and data concerning the fever, thrombocytopenia, abdominal
pain, elevation of liver enzymes and negative results for malaria,
dengue virus infection was suspected. One day after admission,
samples were taken and sent to the CNM for dengue PCR and the
next day for serology.
During an abdominal ultrasound no evidence of injury to the
liver or spleen was observed. Gallbladder and bile ducts were also
normal. On the other hand, the presence of free liquid in the sub-
hepatic area and pouch of Douglas were remarkable. During
hospitalization, the patient also experienced episodes of self-limited
epistaxis, bleeding from venipuncture sites, episodes of hemoptoic
sputum without respiratory or hemodynamic impact, and
increased hyperemia with self-limited subconjunctival hemor-
rhage. Furthermore, the hemoconcentration observed on the 5th
day after onset was very high having risen more than 32% above
baseline.
While admitted, the patient was only treated with supportive
care (hydration and non-inflammatory analgesia), without requir-
ing platelet transfusion. After four days hospitalized, the number of
platelets, liver function and general clinical symptoms started to
show improvement; no new episodes of bleeding or abdominal
pain were observed. Eight days after admission the patient was
discharged.
According to the original WHO definition of DHF [23], the
case met the four criteria for classification as grade II DHF (fever,
thrombocytopenia, hemorrhage and plasma leakage). However,
according to the newly proposed WHO definition [24], the case
would be classified as ‘‘dengue with alarm signs.’’
By day 22, the patient was clinically asymptomatic. All
analytical parameters were normal with a slight increase of AST
and ALT (Table 1).
Virological and serological data
DENV-2 was found in blood and sera in the samples taken 4
and 5 days post onset of fever by routine consensus PCR over the
E/NS1 junction [26]. PCR amplification in the NS5 was also
performed to confirm the initial results (PCR E/NS1 and IFI).
BLAST analysis of the sequence obtained from the PCR products
gave a similarity index of 97% with sylvatic West African lineage
DENV-2 (Accession number EF457904). Both IgM and IgG were
positive in the sera taken at day 6 after onset. The quantitative
results obtained (40.9 for IgM and 58.8 for IgG) suggested a
secondary infection. The avidity assay characterized the IgG
response as high avidity. NS1 antigen was detected in the sample
at high concentration.
Phylogenetic analysis
Phylogenetic analysis from the E/NS1 and NS5 regions
revealed that the sequences fell into DENV 2 sylvatic genotype
group, within the African isolates (data not shown). Complete
genome phylogenetic analysis confirmed that EEB-17 fell within
the West African sylvatic lineage of DENV-2 and was most closely
related to isolates DakAr141069 and DakAr141070 [7] (Figure 2).
Both isolates were detected in 1999 in Ae. luteocephalus mosquitoes
from Kedougou region (South-eastern Senegal) [5]. Interestingly,
sylvatic strains of African origin showed a clustering by year of
isolation. This phylogenetic history was supported by high
posterior probability values (1.0). Molecular clock analysis suggests
that the African sylvatic lineage shares a common ancestor
Dengue Hemorrhagic Fever Caused by Sylvatic Dengue
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DENV-2 has likely been circulating in non-human primates in
Africa for at least this long. Our analysis also predicts the Time to
the Most Recent Common Ancestor (TMRCA) for each of the
human genotypes demonstrating that the divergence of the Asian
and African lineages of sylvatic DENV-2 is comparable to the
observed difference among human lineages. The mean evolution-
ary rates estimated ranged from 3.7610
24 substitutions per site
per year (95% HPD, 1.8610
24 to 5.9610
24).
Discussion
Although sylvatic dengue cycles occur in West African countries
and Malaysia, only a few cases of human disease caused by sylvatic
strains have been reported [5]. Given that infection with sylvatic
DENV may result in clinical presentation indistinguishable from
that presented due to infection with strains from the human
transmission cycle, it is possible that cases of sylvatic dengue are
underreported. Nevertheless, after 30 years of silence, sylvatic
dengue has re-emerged causing severe disease in a young man
[22]. Although silent transmission during those 30 years is possible
(human or sylvatic), no reports suggest it has occurred. We
describe here an imported DHF case caused by a sylvatic strain in
a healthy man returning to Madrid from Guinea Bissau through
Senegal. This is the first report of DHF caused by a sylvatic
DENV-2 West African lineage virus. The patient had dengue fever
with alarming symptoms, such as haemorrhagic manifestations
(mucosal bleeding, hematocrit 32% above baseline), thrombocy-
topenia and fluid accumulation in the abdominal cavity associated
with abdominal pain. Under the old WHO definition, the patient
classifies as grade II DHF with a risk of developing into grade III
[23]. As indicated by the IgG avidity test, the patient showed high
avidity antibodies suggesting a secondary flavivirus infection.
Secondary infection with sylvatic DENV may have resulted after a
primary infection with another dengue serotype, considered a risk
factor for development of DHF[29]; after a primary infection with
another flavivirus, since such viruses circulate throughout Guinea
Bissau and neighbouring nations [30]; or after the development of
immunity resulted by YFV vaccination. The IgM/IgG ratio or
IgG avidity index has limitation to differentiate true dengue
secondary infection in individuals with previous immunity against
other flavivirus[25]. Evidence of previous infection with another
DENV serotype might explain disease severity. Lack of evidence
would suggest severe disease in a primary case of dengue caused by
a sylvatic strain. Unfortunately, we cannot demonstrate previous
infection with another DENV serotype. DENV is endemic in West
Africa; and the predominant serotype with sustained circulation in
the region is DENV-2 from sylvatic or epidemic lineage [31].
DENV-3 was recently detected in Ivory Cost [32] and it continues
to expand throughout the region [20,33]. In Dakar, Senegal,
DENV-3 was detected in 2009 [20].
Based on the incubation period of dengue and previous
knowledge describing the zone of circulation of sylvatic DENV-2
strains in Senegal, we posit that the infection was acquired during
Figure 2. Maximum Clade Credibility (MCC) tree of 906 complete genomes of DENV-2. The six major genotypes are highlighted with
different colors. Sylvatic genotypes from West Africa and Malaysia are colored in red and pink, respectively. The 95% HPD values for most recent
common ancestor are labeled beside the node. Strains are labeled as follow: serotype/country/strain name/year. EEB-17 accession number: JF260983.
Genbank accession numbers of sequences presented in this figure are listed in Text S1.
doi:10.1371/journal.pntd.0001251.g002
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Senegal, via Casamance, a region of documented sylvatic DENV
activity [13]. The following points were considered to build that
hypothesis: i) sylvatic DENV-2 has been frequently isolated in
Senegal [5]; ii) our isolate EEB-17 is closely related to isolates
obtained from Ae. luteocephalus captured in Senegal in the year
1999; iii) absence of sylvatic dengue circulation in Guinea-Bissau;
iv) During October 2009, DENV-3 circulation was identified in
Dakar [20,34], the same time this DENV-2 case was identified.
Moreover, outbreaks in Dakar and in the Kedougou region were
reported [20]. In the Kedougou region, a sylvatic amplification
cycle was detected with the isolation of sylvatic strains during
surveillance activities by Institute Pasteur of Dakar (Dr. Amadou
Sall, personal communication); and vi) Circulation of sylvatic
DENV-2 would follow the same pattern of periodicity of the
epizootics in the area with an interval cycle of approximately 8–9
years [5].
In addition, our complete genome phylogenetic analysis
revealed that EEB-17 belongs to the West African lineage, along
with isolates post-1980. According to the molecular clock, the
African sylvatic lineage has shared a common ancestor approx-
imately 103 years ago. These values are in agreement with
previous reports [7,22]. The mean evolutionary rates estimated
were in complete concordance with the rates obtained by Vasilakis
et al [7].
Introduction of DENV in Europe was observed in the summer
of 2010. Autochthonous circulation of DENV was detected in
France [35] and Croatia [36]. Mosquito surveillance in the
countries on the Mediterranean basin demonstrates the presence
of Ae. albopictus, and highlights the risk of initiation of a local
transmission cycle in the presence of high vector densities. In that
context, DENV strains could be introduced in naı ¨ve countries with
the potential to develop limited or even extensive outbreaks, such
as occurred with the introduction of Chikungunya virus in Italy in
2007 [37].
In summary, we described here the first case of DHF grade II
caused by a sylvatic DENV-2 belonging to a West African lineage
virus. The findings suggest that sylvatic strains of DENV might
have a greater pathogenic potential than previously thought [19].
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